1. Home
  2. TEVA vs MOH Comparison

TEVA vs MOH Comparison

Compare TEVA & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • MOH
  • Stock Information
  • Founded
  • TEVA 1901
  • MOH 1980
  • Country
  • TEVA Israel
  • MOH United States
  • Employees
  • TEVA N/A
  • MOH N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • MOH Medical Specialities
  • Sector
  • TEVA Health Care
  • MOH Health Care
  • Exchange
  • TEVA Nasdaq
  • MOH Nasdaq
  • Market Cap
  • TEVA 20.1B
  • MOH 18.7B
  • IPO Year
  • TEVA N/A
  • MOH 2003
  • Fundamental
  • Price
  • TEVA $16.76
  • MOH $233.17
  • Analyst Decision
  • TEVA Strong Buy
  • MOH Buy
  • Analyst Count
  • TEVA 8
  • MOH 17
  • Target Price
  • TEVA $24.50
  • MOH $363.81
  • AVG Volume (30 Days)
  • TEVA 10.1M
  • MOH 774.3K
  • Earning Date
  • TEVA 07-30-2025
  • MOH 07-23-2025
  • Dividend Yield
  • TEVA N/A
  • MOH N/A
  • EPS Growth
  • TEVA N/A
  • MOH 12.28
  • EPS
  • TEVA N/A
  • MOH 20.69
  • Revenue
  • TEVA $16,616,000,000.00
  • MOH $40,289,000,000.00
  • Revenue This Year
  • TEVA $5.69
  • MOH $13.97
  • Revenue Next Year
  • TEVA N/A
  • MOH $7.84
  • P/E Ratio
  • TEVA N/A
  • MOH $11.24
  • Revenue Growth
  • TEVA 3.82
  • MOH 16.24
  • 52 Week Low
  • TEVA $12.47
  • MOH $230.96
  • 52 Week High
  • TEVA $22.80
  • MOH $365.23
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 47.80
  • MOH 22.09
  • Support Level
  • TEVA $16.55
  • MOH $236.37
  • Resistance Level
  • TEVA $17.30
  • MOH $311.52
  • Average True Range (ATR)
  • TEVA 0.39
  • MOH 9.49
  • MACD
  • TEVA -0.05
  • MOH -6.62
  • Stochastic Oscillator
  • TEVA 38.89
  • MOH 0.00

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About MOH Molina Healthcare Inc

Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

Share on Social Networks: